# Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes

> **NCT06825182** · PHASE3 · RECRUITING · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 1000 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Outpatient newly diagnosed type 2 diabetes subjects
- **DRUG:** Inpatient newly diagnosed type 2 diabetes subjects

## Key facts

- **NCT ID:** NCT06825182
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-07
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06825182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06825182, "Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06825182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*